Caris Life Sciences (CAI) Net Cash Flow (2024 - 2026)
Caris Life Sciences (CAI) posted quarterly Net Cash Flow of $23.4 million for Q1 2026, up 171.34% year-over-year from $8.6 million in Q1 2025, and down 45.79% quarter-over-quarter from $43.1 million in Q4 2025.
Caris Life Sciences (CAI) Net Cash Flow (2024 - 2026) Analysis & Trends
Caris Life Sciences' Net Cash Flow history runs 3 years deep, the most recent figure standing at $23.4 million for Q1 2026.
- In Q1 2026, Net Cash Flow rose 171.34% year-over-year to $23.4 million; the TTM figure through Mar 2026 stood at $788.0 million (up 643.83% YoY), while the FY2025 annual figure was $731.9 million, up 9020.05% from the prior year.
- Net Cash Flow for Q1 2026 stood at $23.4 million, down from $43.1 million in the prior quarter.
- The five-year high for Net Cash Flow was $687.3 million in Q2 2025, with the low at -$71.2 million in Q3 2024.
- The 3-year median for Net Cash Flow is $23.4 million (2026), against an average of $91.9 million.
- Peak annual rise in Net Cash Flow reached 205.13% in 2025, while the deepest fall reached 148.1% in 2025.
- Caris Life Sciences' Net Cash Flow stood at -$41.0 million in 2024, then soared by 205.13% to $43.1 million in 2025, then tumbled by 45.79% to $23.4 million in 2026.
- Business Quant data shows CAI's Net Cash Flow at $23.4 million in Q1 2026, $43.1 million in Q4 2025, and $34.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 407.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 17.81 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -496,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.14 Mn |
| 10 | Caris Life Sciences | 6.16 Bn | 5.37 Bn | 182.38 Mn | -130.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -130.62 Mn |
| Jun 30, 2026 | -130.62 Mn |
| Mar 31, 2026 | 23.36 Mn |
| Mar 31, 2026 | 23.36 Mn |
| Dec 31, 2025 | 43.09 Mn |
| Dec 31, 2025 | 43.09 Mn |
| Sep 30, 2025 | 34.23 Mn |
| Sep 30, 2025 | 34.23 Mn |
| Jun 30, 2025 | 687.30 Mn |
| Jun 30, 2025 | 687.30 Mn |
| Mar 31, 2025 | -32.74 Mn |
| Mar 31, 2025 | -32.74 Mn |
| Dec 31, 2024 | -40.99 Mn |
| Dec 31, 2024 | -40.99 Mn |
| Sep 30, 2024 | -71.17 Mn |
| Sep 30, 2024 | -71.17 Mn |